Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jul;323(3):276-7.
doi: 10.1007/BF00497674.

Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110

D R Ferry, A Goll, H Glossmann

Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110

D R Ferry et al. Naunyn Schmiedebergs Arch Pharmacol. 1983 Jul.

Abstract

Four 1,4-dihydropyridine calcium channel blockers [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110 (Isopropyl 4-(2,1,3,benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-methoxy- carbonylpyridine-3-carboxylate) were employed to label putative calcium channels in guinea-pig hind limb skeletal muscle membranes. The four radioligands differed with respect to the number of sites (Bmax) which were labelled. The following rank order of Bmax values was found: PN 200 110 greater than nimodipine = nitrendipine greater than nifedipine. d-cis-Diltiazem caused an increase in the density of high-affinity binding sites for all four calcium channel blockers. The relative stimulation was smallest for PN 200 110. It is suggested that 1,4-dihydropyridines exhibit different efficacies for induction of a channel state with high affinity for these drugs.

PubMed Disclaimer

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):11-9 - PubMed
    1. FEBS Lett. 1983 Feb 21;152(2):191-4 - PubMed
    1. Eur J Pharmacol. 1982 Dec 17;86(1):141-2 - PubMed
    1. FEBS Lett. 1982 Nov 8;148(2):331-7 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1983 Jun;323(1):1-11 - PubMed